168 related articles for article (PubMed ID: 36402872)
1. Conventional and drug-eluting beads transarterial chemoembolization in patients with unresectable intrahepatic cholangiocarcinoma: a systematic review and pooled analysis.
He M; Jiang N; Yin X; Xu A; Mu K
J Cancer Res Clin Oncol; 2023 Jan; 149(1):531-540. PubMed ID: 36402872
[TBL] [Abstract][Full Text] [Related]
2. Efficacy and Safety of Drug-Eluting Beads Transarterial Chemoembolization Combining Immune Checkpoint Inhibitors in Unresectable Intrahepatic Cholangiocarcinoma: A Propensity Score Matching Analysis.
Yang XG; Sun YY; Li DS; Xu GH; Huang XQ
Front Immunol; 2022; 13():940009. PubMed ID: 35874708
[TBL] [Abstract][Full Text] [Related]
3. Systemic chemotherapy plus transarterial chemoembolization versus systemic chemotherapy alone for unresectable intrahepatic cholangiocarcinoma: a multicenter retrospective cohort study.
Jiang N; Zhang Z; Yin X; Qiu H; Yan W; Hao Y; Yang W; Li H; Xu A; Mu K
Radiol Med; 2024 Apr; 129(4):631-642. PubMed ID: 38355907
[TBL] [Abstract][Full Text] [Related]
4. Treatment of unresectable intrahepatic cholangiocarcinoma using transarterial chemoembolisation with irinotecan-eluting beads: analysis of efficacy and safety.
Liu D; Wang J; Ma Z; Zhang N; Zhao Y; Yang X; Wen Z; Xie H
Cardiovasc Intervent Radiol; 2022 Aug; 45(8):1092-1101. PubMed ID: 35588011
[TBL] [Abstract][Full Text] [Related]
5. Drug-eluting beads transarterial chemoembolization by CalliSpheres is effective and well tolerated in treating intrahepatic cholangiocarcinoma patients: A preliminary result from CTILC study.
Luo J; Zheng J; Shi C; Fang J; Peng Z; Huang J; Sun J; Zhou G; Li T; Zhu D; Xu H; Hou Q; Ying S; Sun Z; Du H; Xie X; Cao G; Ji W; Han J; Gu W; Guo X; Shao G; Yu Z; Zhou J; Yu W; Zhang X; Li L; Hu H; Hu T; Wu X; Chen Y; Ji J; Hu W
Medicine (Baltimore); 2020 Mar; 99(12):e19276. PubMed ID: 32195932
[TBL] [Abstract][Full Text] [Related]
6. Transarterial Chemoembolization and Radioembolization for Unresectable Intrahepatic Cholangiocarcinoma-a Systemic Review and Meta-Analysis.
Mosconi C; Solaini L; Vara G; Brandi N; Cappelli A; Modestino F; Cucchetti A; Golfieri R
Cardiovasc Intervent Radiol; 2021 May; 44(5):728-738. PubMed ID: 33709272
[TBL] [Abstract][Full Text] [Related]
7. A comparative study of efficacy and safety of transarterial chemoembolization with CalliSpheres and conventional transarterial chemoembolization in treating unresectable intrahepatic cholangiocarcinoma patients.
Sun T; Zhang W; Chen L; Ren Y; Liu Y; Zheng C
J Cancer; 2022; 13(4):1282-1288. PubMed ID: 35281867
[No Abstract] [Full Text] [Related]
8. Treatment of unresectable cholangiocarcinoma: conventional transarterial chemoembolization compared with drug eluting bead-transarterial chemoembolization and systemic chemotherapy.
Kuhlmann JB; Euringer W; Spangenberg HC; Breidert M; Blum HE; Harder J; Fischer R
Eur J Gastroenterol Hepatol; 2012 Apr; 24(4):437-43. PubMed ID: 22261548
[TBL] [Abstract][Full Text] [Related]
9. A comparison between drug-eluting bead-transarterial chemoembolization and conventional transarterial chemoembolization in patients with hepatocellular carcinoma: A meta-analysis of six randomized controlled trials.
Wang H; Cao C; Wei X; Shen K; Shu Y; Wan X; Sun J; Ren X; Dong Y; Liu Y; Zhai B
J Cancer Res Ther; 2020; 16(2):243-249. PubMed ID: 32474508
[TBL] [Abstract][Full Text] [Related]
10. Adjuvant Transarterial Chemoembolization for Patients with Intrahepatic Cholangiocarcinoma after Surgical Resection: A Systematic Review and Meta-analysis.
Wang L; Wen X; Zhuang L; Fang K; Shen J
J Gastrointestin Liver Dis; 2022 Jun; 31(2):215-222. PubMed ID: 35574621
[TBL] [Abstract][Full Text] [Related]
11. Comparative effectiveness of hepatic artery based therapies for unresectable intrahepatic cholangiocarcinoma.
Boehm LM; Jayakrishnan TT; Miura JT; Zacharias AJ; Johnston FM; Turaga KK; Gamblin TC
J Surg Oncol; 2015 Feb; 111(2):213-20. PubMed ID: 25176325
[TBL] [Abstract][Full Text] [Related]
12. Systematic Review and Pharmacokinetic Meta-analysis of Doxorubicin Exposure in Transcatheter Arterial Chemoembolization and Doxorubicin-Eluted Beads Chemoembolization for Treatment of Unresectable Hepatocellular Carcinoma.
Zarisfi M; Kasaeian A; Wen A; Liapi E
Eur J Drug Metab Pharmacokinet; 2022 Jul; 47(4):449-466. PubMed ID: 35543895
[TBL] [Abstract][Full Text] [Related]
13. Treating unresectable intrahepatic cholangiocarcinoma with transarterial chemoembolization and an unusual progression with cardiac involvement.
Mumdzhiev N; Borisov B; Tenev R; Radicheva M
Folia Med (Plovdiv); 2023 Apr; 65(2):326-330. PubMed ID: 37144321
[TBL] [Abstract][Full Text] [Related]
14. Chemoembolization with Drug-eluting Microspheres Loaded with Doxorubicin for the Treatment of Cholangiocarcinoma.
Aliberti C; Carandina R; Sarti D; Pizzirani E; Ramondo G; Mulazzani L; Mattioli GM; Fiorentini G
Anticancer Res; 2017 Apr; 37(4):1859-1863. PubMed ID: 28373452
[TBL] [Abstract][Full Text] [Related]
15. Meta-analysis: adjusted indirect comparison of drug-eluting bead transarterial chemoembolization versus
Ludwig JM; Zhang D; Xing M; Kim HS
Eur Radiol; 2017 May; 27(5):2031-2041. PubMed ID: 27562480
[TBL] [Abstract][Full Text] [Related]
16. Doxorubicin-eluting beads versus conventional transarterial chemoembolization for the treatment of hepatocellular carcinoma.
Huang K; Zhou Q; Wang R; Cheng D; Ma Y
J Gastroenterol Hepatol; 2014 May; 29(5):920-5. PubMed ID: 24224722
[TBL] [Abstract][Full Text] [Related]
17. Efficacy of transarterial chemoembolization with drug-eluting beads combined with systemic chemotherapy and targeted therapy in colorectal cancer liver metastasis.
Chen YC; Huang CW; Li CC; Chang TK; Su WC; Chen PJ; Yeh YS; Chang YT; Tsai HL; Shih MP; Wang JY
World J Surg Oncol; 2023 Dec; 21(1):378. PubMed ID: 38041083
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the efficacy and safety among apatinib plus drug-eluting bead transarterial chemoembolization (TACE), apatinib plus conventional TACE and apatinib alone in advanced intrahepatic cholangiocarcinoma.
Hu Y; Hao M; Chen Q; Chen Z; Lin H
Am J Transl Res; 2020; 12(10):6584-6598. PubMed ID: 33194055
[TBL] [Abstract][Full Text] [Related]
19. OEM-TACE: a new therapeutic approach in unresectable intrahepatic cholangiocarcinoma.
Poggi G; Amatu A; Montagna B; Quaretti P; Minoia C; Sottani C; Villani L; Tagliaferri B; Sottotetti F; Rossi O; Pozzi E; Zappoli F; Riccardi A; Bernardo G
Cardiovasc Intervent Radiol; 2009 Nov; 32(6):1187-92. PubMed ID: 19727937
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of drug-eluting beads versus conventional transcatheter arterial chemoembolization in patients with unresectable hepatocellular carcinoma: A systematic review and meta-analysis.
Chen P; Yuan P; Chen B; Sun J; Shen H; Qian Y
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):75-85. PubMed ID: 27350573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
